I

IconOVir Bio

30 employees

IconOVir Bio is a preclinical-stage biotechnology company developing oncolytic virus therapy for the treatment of patients with cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical
Life Science

Date founded

2018

Funding rounds raised

Total raised

$77M

from 8 investors over 8 rounds

I

IconOVir Bio raised $77M on January 5, 2021

Investors: Nextech Invest, Bellco Capital, Logos Global Management, LP, Wellington Partners, Two River, GV, Polaris Partners and Vida Ventures, LLC

FAQ